Product Information
POLY-VENT DM TABLET is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.6289 per EA under NDC 50991021401. Its NADAC has been published 180 times since Feb 17, 2016.
Strength
20; 380; 60 mg/1; mg/1; mg/1
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991021401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/17/2025
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/17/2013
Pharmacological Classes
Price Statistics
The NADAC for POLY-VENT DM TABLET has been published 180 times since Feb 17, 2016, and over the history we have for it it has declined 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6289 per EA |
|---|---|
| All-time high | $0.6572 (Feb 15, 2017) |
| All-time low | $0.6269 (Feb 19, 2025) |
| 52-week high | $0.6289 |
| 52-week low | $0.6289 |
| Median price | $0.6289 |
| Average price | $0.6374 |
| Largest weekly change | -4.0% (Apr 17, 2024) |
| Weeks tracked | 180 |
| Tracking since | Feb 17, 2016 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
-4.3%
5Y
-4.3%
All
-4.3%
Last surveyed Sep 16, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Poly Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POLY-VENT DM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POLY-VENT DM TABLET, manufactured by Poly Pharmaceuticals, Inc., is $0.6289 per EA (NDC 50991021401), effective Sep 16, 2026.
How has the price of POLY-VENT DM TABLET changed over time?
Over the history we have for it, the NADAC for POLY-VENT DM TABLET has declined 4.3%. It has been tracked across 180 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for POLY-VENT DM TABLET?
Since Feb 17, 2016, the NADAC for POLY-VENT DM TABLET has ranged from a low of $0.6269 (Feb 19, 2025) to a high of $0.6572 (Feb 15, 2017), with a median of $0.6289 per EA.
Are there cheaper alternatives to POLY-VENT DM TABLET?
No other NADAC-published product currently shares the active ingredient and strength of POLY-VENT DM TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POLY-VENT DM TABLET?
POLY-VENT DM TABLET (NDC 50991021401) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.